Brain-Computer Interface (BCI) technology, which facilitates the transmission of neural signals from a person's brain to a computer, was once confined to the realm of science fiction. Today, however, this advanced technology constitutes a burgeoning and competitive segment of the tech industry. Among the companies actively pursuing the commercialization of BCI is Neurable, which recently announced its intention to license its "mind-reading" technology for integration into consumer wearables.
Neurable specializes in "non-invasive" BCI, a key differentiator from firms such as Neuralink, the Elon Musk-founded startup known for surgically implanting computer chips directly into people’s skulls. Neurable's approach ensures that users can access the benefits of its product without the need for invasive brain surgery.
The core of Neurable’s technology lies in its combination of EEG sensors and sophisticated signal processing. This system is capable of scanning and analyzing a user's brain activity with artificial intelligence, subsequently providing valuable insights into their cognitive performance.
In December, Neurable successfully secured $35 million in Series A funding, which it plans to allocate towards scaling the commercialization of its technology. This week, as part of its strategic expansion, the company declared its aim to license its technology to a diverse range of consumer-facing businesses.
The vision is to integrate this "mind-reading" technology, which offers detailed data on brain function during various activities, into wearables across multiple sectors. These include health and athletic products, productivity tools, and gaming. According to a press release issued on Tuesday, the company stated, “Through Neurable’s licensing platform, OEMs can directly integrate its AI-powered brain-sensing technology into existing hardware, such as headphones, hats, glasses, and headbands, while maintaining full control over product design, user experience, and distribution.”
Neurable has already forged strategic partnerships to demonstrate the effectiveness of its technology. This includes a collaboration with HP Inc.’s HyperX, a prominent gaming brand, resulting in the creation of a headset designed to help gamers “level up their game play by optimizing focus and performance.” The company has also partnered with iMotions, a software platform dedicated to human behavior research, to support its ongoing research initiatives.
In a recent interview, Neurable’s CEO, Ramses Alcaide, refrained from disclosing details about new partnerships currently in development but affirmed the company’s ambition to broaden its scope across a multitude of domains.
Alcaide elaborated on the company's evolving strategy, stating, “In the past, we were very specific about our partnerships.” He noted that Neurable previously concentrated on individual companies to validate the viability of unique commercial applications. Now, with proven success across various fronts, the startup is primarily focused on scaling its operations.
“What we’re doing now is we’re basically saying, like, ‘Hey, we’ve demonstrated that we’re getting great traction’,” Alcaide explained. He further articulated the company’s aspiration: “Like, let’s make this as ubiquitous as heart rate sensors on your wrist, right?”
Despite the designation of "non-invasive," brain data is inherently more intimate and sensitive than information gathered from a heart rate sensor. This raises important questions regarding the privacy protections implemented by a company like Neurable.
Alcaide affirmed that the company guarantees user data is “protected and anonymized.” He pointed to Neurable’s privacy policy, which outlines comprehensive guidelines for when and how user data may be accessed and utilized. “We make sure we follow HIPAA standards, like we’ve gone above and beyond where a lot of startups would be at our stage to make sure that we protect the data, we encrypt it, and that we anonymize it,” Alcaide emphasized.
When questioned about whether Neurable leverages user neural data to train its AI software, Alcaide responded, “We can with user consent, right? But we do it in a very specific way.” He clarified that this specific approach involves explicitly asking users for permission to use their data for particular experiments. “We are not collecting the data, just training on it willy nilly,” he asserted, underscoring that this type of data usage is highly targeted and consent-driven.
Alcaide described his industry as being at an “inflection point”—a moment where “a real business model in neuro-technology that is scalable” has finally emerged. The crucial question, he noted, is what developments will follow this significant turning point.